Abstract：Objective To observe expression of human beta-defensin-3 (HBD-3) in tissues around the infected artificial prostheses and investigate its value in treatment and diagnosis of periprosthetic joint infection (PJI). Methods According to clinical diagnosis, periprosthetic tissues and normal synovial membrane excised in operation were collected and divided into the following four groups: PJI group (n=13), aseptic loosening group (loosening group, n=9), spacer treatment group (treatment group, n=12), and normal group (n=15). HE staining was used to observe infiltration of inflammatory cells. Immunofluorescence staining was used to detect positive cells number and fluorescence intensity. Image-pro plus (IPP) 7.0C software was used to measure the average value of absorbance. Preoperative peripheral white blood cell count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) results were documented. Then, differences of those parameters were analyzed and compared among groups. Results HE staining revealed that all groups had different degree of inflammatory cell infiltration except for normal group. Immunofluorescence staining revealed that the most number of positive cells and highest fluorescence intensity existed in PJI group. Value of absorbance in PJI group was 0.430±0.013, followed by 0.308±0.005 in loosening group,0.234±0.009 in treatment group, and 0.089±0.019 in normal group. Preoperative peripheral white blood cell count, ESR and CRP were the highest in PFI group, but were not significantly different among the remaining three groups. Conclusion HBD-3 is highly expressed in tissues around the prostheses which had infection or aseptic loosening, but its expression in response to infection and loosening has difference.
LUO Xi,FEI Jun,DU Shun-hua et al. Expression of human beta-defensin-3 in surrounding tissues of infected artificial prostheses[J]. CHINESE JOURNAL OF TRAUMA, 2013, 29(5): 456-460.
［1］Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection, 2003, 31(2):99-108.
［2］Di Cesare PE, Chang E, Preston CF, et al. Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg (Am), 2005, 87(9):1921-1927.
［3］Della Valle CJ, Sporer SM, Jacobs JJ, et al. Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplasty, 2007, 22(6 Suppl 2):90-93.
［6］Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science, 1999, 284(5418):1318-1322.
［7］Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Micribiol, 1999, 37(10):3281-3290.
［8］Beisswenger C, Bals R. Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci, 2005, 6(3):255-264.
［9］Dubin A, Mak P, Dubin G, et al. New generation of peptide antibiotics. Acta Biochim Pol, 2005, 52(3):633-638.
［10］Selsted ME, Tang YQ, Morris WL, et al. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem, 1993, 268(9):6641-6648.
［11］Paulsen F, Pufe T, Conradi L, et al. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol, 2002, 198(3):369-377.
［12］Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem, 2001, 276(8):5707-5713.
［13］García JR, Jaumann F, Sehulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oeytes and the induction of macrophage chemoattraction. Cell Tissue Res, 2001, 306(2):257-264.
［14］Dressel S, Harder J, Cordes J, et al. Differential expression of antimicrobial peptides in margins of chronic wounds. Exp Dermatol, 2010, 19(7):628-632.
［15］Shuyi Y, Feng W, Jing T, et al. Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 112(5):616-625.
［16］Harris WH. Wear and periproshetic osteolysis: the problem. Clin Orthop Relat Res, 2001, （393）:66-70.
［17］Matthews JB, Besong AA,Green TR, et al. Evaluation of the response of primary human peripheral blood mononuclear phagocytes to challenge with in vitro generated clinically relevant UHMWPE particles of known size and dose. J Biomed Mater Res, 2000, 52(2):296-307.
［18］Trampuz A, Hanssen AD, Osmon DR, et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med, 2004, 117(8):556-562.
［19］Sarda-Mantel L, Saleh-Mghir A, Welling MM, et al. Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. Eur J Nucl Med Mol Imaging, 2007, 34(8):1302-1309.
［20］Deirmengian C, Hallab N, Tarabishy A, et al. Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res, 2010, （468):2017-2023.
